Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/113274
DC FieldValueLanguage
dc.contributor.authorPinho, Sónia A.-
dc.contributor.authorAnjo, Sandra I.-
dc.contributor.authorCunha-Oliveira, Teresa-
dc.date.accessioned2024-02-12T11:33:37Z-
dc.date.available2024-02-12T11:33:37Z-
dc.date.issued2023-05-10-
dc.identifier.issn2076-3921pt
dc.identifier.urihttps://hdl.handle.net/10316/113274-
dc.description.abstractTheragnostics is a promising approach that integrates diagnostics and therapeutics into a single personalized strategy. To conduct effective theragnostic studies, it is essential to create an in vitro environment that accurately reflects the in vivo conditions. In this review, we discuss the importance of redox homeostasis and mitochondrial function in the context of personalized theragnostic approaches. Cells have several ways to respond to metabolic stress, including changes in protein localization, density, and degradation, which can promote cell survival. However, disruption of redox homeostasis can lead to oxidative stress and cellular damage, which are implicated in various diseases. Models of oxidative stress and mitochondrial dysfunction should be developed in metabolically conditioned cells to explore the underlying mechanisms of diseases and develop new therapies. By choosing an appropriate cellular model, adjusting cell culture conditions and validating the cellular model, it is possible to identify the most promising therapeutic options and tailor treatments to individual patients. Overall, we highlight the importance of precise and individualized approaches in theragnostics and the need to develop accurate in vitro models that reflect the in vivo conditions.pt
dc.description.sponsorshipEXPL/BTM-TEC/1407/2021; DL57/2016/CP1448/CT0016;pt
dc.language.isoengpt
dc.publisherMDPIpt
dc.relationCENTRO-01-0246-FEDER-000010pt
dc.relationPTDC/BTM-SAL/29297/2017pt
dc.relationUIDB/04539/2020pt
dc.relationinfo:eu-repo/grantAgreement/UIDP/04539/2020pt
dc.relationLA/P/0058/2020pt
dc.relationSFRH/PD/BD/143055/2018pt
dc.relation2021.04378.CEECINDpt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectmetabolic primingpt
dc.subjecttheragnosticspt
dc.subjectmitochondriapt
dc.subjectredox homeostasispt
dc.subjectmedia compositionpt
dc.subjectoxygen levelspt
dc.titleMetabolic Priming as a Tool in Redox and Mitochondrial Theragnosticspt
dc.typearticle-
degois.publication.firstPage1072pt
degois.publication.issue5pt
degois.publication.titleAntioxidantspt
dc.peerreviewedyespt
dc.identifier.doi10.3390/antiox12051072pt
degois.publication.volume12pt
dc.date.embargo2023-05-10*
uc.date.periodoEmbargo0pt
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.project.grantnoMitoScreening- Development and validation of innovative screening methods for mitochondrial health modulators-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology - CIBB-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology - Associate Laboratory-
crisitem.author.orcid0000-0002-7382-0339-
Appears in Collections:I&D CIBB - Artigos em Revistas Internacionais
IIIUC - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
Files in This Item:
Show simple item record

Page view(s)

109
checked on Oct 9, 2024

Download(s)

78
checked on Oct 9, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons